By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys today announced a partnership with The Edge Software Consultancy to offer new assay, study management, and analysis software solutions to the biopharmaceutical industry.

The software products to be developed by the companies are directed at improving R&D efficiency and productivity of biopharmaceutical firms performing early-stage screening through ADME, DMPK, pharmacology, and in vivo experiments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.